Evidence map›Paper›PMID 40508068›Full record

ArticleInternational journal of molecular sciences2025

Olfactory Perception in Parkinson's Disease: The Impact of

Mikhal E Cohen, Yosef Shechter, Melania Dominko, Elena Shulman, Tama Dinur, Shoshana Revel-Vilk, Roni Eichel, Gilad Yahalom, Michal Becker-Cohen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mikhal E CohenDepartment of Neurology, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.ORCID 0000-0002-0267-2658
Yosef ShechterDepartment of Neurology, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Melania DominkoDepartment of Neurology, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Elena ShulmanGaucher Unit, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.ORCID 0009-0006-2088-0422
Tama DinurFaculty of Medicine, Hebrew University, Jerusalem 9112102, Israel.
Shoshana Revel-VilkFaculty of Medicine, Hebrew University, Jerusalem 9112102, Israel.ORCID 0000-0001-9151-0337
Roni EichelDepartment of Neurology, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Gilad YahalomDepartment of Neurology, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Michal Becker-CohenFaculty of Medicine, Hebrew University, Jerusalem 9112102, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) associated with

Indexed as

GlucosylceramidaseOlfaction DisordersOlfactory PerceptionParkinson DiseaseAdultAgedCase-Control StudiesFemaleGaucher DiseaseHumansMaleMiddle AgedMutationGBA protein, humanGlucosylceramidaseGBA1 varianthyposmiaParkinson’s diseaseSidransky syndromesmell

Identifiers

PMID40508068
PMCPMC12155523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.